查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美內皮功能障礙市場預測至 2028 年 - 區域分析 - 按原因、測試類型和最終用戶
市場調查報告書
商品編碼
1420203

北美內皮功能障礙市場預測至 2028 年 - 區域分析 - 按原因、測試類型和最終用戶

North America Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 115 Pages | 訂單完成後即時交付

價格

北美內皮功能障礙市場預計將從2022年的9.5183億美元成長到2028年的12.473億美元。預計2022年至2028年CAGR為4.6%。

心血管疾病發生率的增加推動了北美內皮功能障礙市場

根據世界衛生組織 (WHO) 的數據，心血管疾病 (CVD) 是全球主要死亡原因之一，每年約有 3000 萬人中風。 CVD包括腦血管疾病、冠狀動脈心臟病、風濕性心臟病和冠狀動脈疾病(CAD)。 CAD是所有心血管疾病中最常見的疾病，其特徵是脂質和免疫細胞在冠狀動脈內皮下間隙積聚或動脈粥狀硬化。它涉及血管內皮的發炎反應。 CAD的特徵是由於動脈粥狀硬化導致冠狀動脈管腔變窄、痙攣或阻塞而導致心肌缺血、缺氧或壞死。它已成為全世界死亡的主要原因。根據美國疾病管制與預防中心 (CDC) 的數據，美國有超過 6,000 萬名女性 (44%) 患有某種形式的心臟病。心臟病是美國女性死亡的主要原因，可以影響任何年齡層的女性。 2021年，它造成了310,661名女性死亡，即近五分之一的女性死亡。

根據美國心臟協會的數據，美國幾乎一半的成年人患有某種類型的心血管疾病。預計到 2035 年，將有超過 1.3 億人（即美國人口的 45.1%）患有某種類型的心血管疾病。因此，內皮功能障礙導致的心血管疾病的高盛行率推動了市場的發展。

北美內皮功能障礙市場概述

北美內皮功能障礙市場以三個主要國家為基礎進行分析：美國、加拿大和墨西哥。該地區的市場擴張可歸因於心臟病發病率的增加和心臟病資訊學投資的增加。由於CAD負擔日益增加、醫療基礎設施完善以及為開發先進的內皮功能障礙藥物和設備而開展的研發活動等因素，美國擁有北美最大的內皮功能障礙市場規模。

北美內皮功能障礙市場收入及 2028 年預測（百萬美元）

北美內皮功能障礙市場細分

北美內皮功能障礙市場按原因、測試類型、最終用戶和國家進行細分。

根據病因，北美內皮功能障礙市場分為高血壓、高膽固醇血症、肥胖、糖尿病、白塞氏症等。 2022 年，高血壓細分市場在北美內皮功能障礙市佔率最大。

根據測試類型，北美內皮功能障礙市場分為侵入性測試和非侵入性測試。到2022 年，侵入性測試細分市場將佔據較大的北美內皮功能障礙市場佔有率。非侵入性測試細分市場進一步細分為血流介導擴張、週邊動脈張力測定(PAT)、靜脈閉塞體積描記術、循環標記物等。

根據最終用戶，北美內皮功能障礙市場可分為醫院、診斷中心、診所等。 2022 年，醫院細分市場佔據北美最大的內皮功能障礙市場。

根據國家/地區，北美內皮功能障礙市場分為美國、加拿大和墨西哥。 2022 年，美國主導北美內皮功能障礙市場。

ZOLL Medical Corp、勞倫斯伯克利國家實驗室、Endothelix Inc、Perimed AB、SMART Medical Ltd、Everist Health Inc 和 Medizinische Messtechnik GmbH 是該地區內皮功能障礙市場的一些領先公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 北美內皮功能障礙市場 - 按原因分類
    • 北美內皮功能障礙市場 - 按測試類型
    • 北美內皮功能障礙市場 - 按最終用戶
    • 北美內皮功能障礙市場 - 按國家/地區

第 2 章：北美內皮功能障礙市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美內皮功能障礙市場 - 市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
  • 專家意見

第 5 章：北美內皮功能障礙市場 - 主要市場動態

  • 市場促進因素
    • 心血管疾病發生率增加
    • 高膽固醇、糖尿病和肥胖症的發生率上升
  • 市場限制
    • 內皮功能障礙篩檢技術的缺點
  • 市場機會
    • 新型生物標記和治療策略的使用不斷增加
  • 未來的趨勢
    • 使用非侵入性方法評估內皮功能障礙
  • 影響分析

第 6 章：內皮功能障礙市場 - 北美分析

  • 北美內皮功能障礙市場收入預測與分析

第 7 章：北美內皮功能障礙市場分析 - 按原因

  • 概述
  • 北美內皮功能障礙市場，依原因分類，2022 年和 2028 年 (%)
  • 高血壓
  • 糖尿病
  • 高膽固醇血症
  • 白塞氏症
  • 肥胖
  • 其他

第 8 章：北美內皮功能障礙市場分析 - 按測試類型

  • 概述
  • 北美內皮功能障礙市場，按測試類型，2022 年和 2028 年 (%)
  • 侵入性測試
  • 非侵入性測試

第 9 章：北美內皮功能障礙市場分析 - 按最終用戶

  • 概述
  • 北美內皮功能障礙市場，按最終用戶分類，2022 年和 2028 年 (%)
  • 醫院
  • 診斷中心
  • 診所
  • 其他

第 10 章：北美內皮功能障礙市場 - 收入和 2028 年預測 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 11 章：北美內皮功能障礙市場-產業格局

  • 概述
  • 內皮功能障礙市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • ZOLL Medical Corp
  • Lawrence Berkeley National Laboratory
  • Endothelix Inc
  • Perimed AB
  • SMART Medical Ltd
  • Everist Health Inc
  • Medizinische Messtechnik GmbH

第 13 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00029161

The North America endothelial dysfunction market is expected to grow from US$ 951.83 million in 2022 to US$ 1,247.30 million by 2028. It is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

Increasing Incidences of Cardiovascular Diseases Fuels North America Endothelial Dysfunction Market

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. Therefore, the high prevalence of cardiovascular diseases due to endothelial dysfunction drives the market.

North America Endothelial Dysfunction Market Overview

The North American endothelial dysfunction market is analyzed on the basis of three major countries: the US, Canada, and Mexico. The market expansion in the region can be attributed to an increase in the incidence of cardiac diseases and rising investments in cardiology informatics. The US holds the largest size of the endothelial dysfunction market in North America owing to factors such as the increasing burden of CAD, established healthcare infrastructure, and R&D activities undertaken to develop advanced endothelial dysfunction drugs and devices.

North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

North America Endothelial Dysfunction Market Segmentation

The North America endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the North America endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest North America endothelial dysfunction market share in 2022.

Based on test type, the North America endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger North America endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the North America endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest North America endothelial dysfunction market share in 2022.

Based on country, the North America endothelial dysfunction market is segmented into the US, Canada, and Mexico. The US dominated the North America endothelial dysfunction market in 2022.

ZOLL Medical Corp, Lawrence Berkeley National Laboratory, Endothelix Inc, Perimed AB, SMART Medical Ltd, Everist Health Inc, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Endothelial Dysfunction Market - by Cause
    • 1.3.2 North America Endothelial Dysfunction Market - by Test Type
    • 1.3.3 North America Endothelial Dysfunction Market - by End User
    • 1.3.4 North America Endothelial Dysfunction Market - by Country

2. North America Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - North America Analysis

  • 6.1 North America Endothelial Dysfunction Market Revenue Forecast and Analysis

7. North America Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 North America Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. North America Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 North America Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. North America Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 North America Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. North America Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 North America: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. North America Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Lawrence Berkeley National Laboratory
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Endothelix Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Perimed AB
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6
    • 12.4.7 Key Developments
  • 12.5 SMART Medical Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Everist Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medizinische Messtechnik GmbH
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. US Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 16. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 17. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. North America Endothelial Dysfunction Market Segmentation
  • Figure 2. North America Endothelial Dysfunction Market, by Country
  • Figure 3. North America Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in North America Endothelial Dysfunction Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. North America Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. North America Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. North America Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. North America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. US: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Growth Strategies in the Endothelial Dysfunction Market